166 related articles for article (PubMed ID: 12558191)
1. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes.
Holmes JH; Connolly NC; Paull DL; Hill ME; Guyton SW; Ziegler SF; Hall RA
Inflamm Res; 2002 Dec; 51(12):579-86. PubMed ID: 12558191
[TBL] [Abstract][Full Text] [Related]
2. The relationship between inflammatory activation and clinical outcome after infant cardiopulmonary bypass.
Allan CK; Newburger JW; McGrath E; Elder J; Psoinos C; Laussen PC; del Nido PJ; Wypij D; McGowan FX
Anesth Analg; 2010 Nov; 111(5):1244-51. PubMed ID: 20829561
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass.
Ascione R; Lloyd CT; Underwood MJ; Lotto AA; Pitsis AA; Angelini GD
Ann Thorac Surg; 2000 Apr; 69(4):1198-204. PubMed ID: 10800819
[TBL] [Abstract][Full Text] [Related]
4. Complement and the damaging effects of cardiopulmonary bypass.
Kirklin JK; Westaby S; Blackstone EH; Kirklin JW; Chenoweth DE; Pacifico AD
J Thorac Cardiovasc Surg; 1983 Dec; 86(6):845-57. PubMed ID: 6606084
[TBL] [Abstract][Full Text] [Related]
5. Normothermia has beneficial effects in cardiopulmonary bypass attenuating inflammatory reactions.
Ohata T; Sawa Y; Kadoba K; Taniguchi K; Ichikawa H; Masai T; Shimazaki Y; Matsuda H
ASAIO J; 1995; 41(3):M288-91. PubMed ID: 8573808
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory mediator removal by zero-balance ultrafiltration during cardiopulmonary bypass.
Tallman RD; Dumond M; Brown D
Perfusion; 2002 Mar; 17(2):111-5. PubMed ID: 11958301
[TBL] [Abstract][Full Text] [Related]
7. Effects of cardiopulmonary bypass on neonatal and paediatric inflammatory profiles.
Ashraf SS; Tian Y; Zacharrias S; Cowan D; Martin P; Watterson K
Eur J Cardiothorac Surg; 1997 Dec; 12(6):862-8. PubMed ID: 9489870
[TBL] [Abstract][Full Text] [Related]
8. Early prediction of capillary leak syndrome in infants after cardiopulmonary bypass.
Kubicki R; Grohmann J; Siepe M; Benk C; Humburger F; Rensing-Ehl A; Stiller B
Eur J Cardiothorac Surg; 2013 Aug; 44(2):275-81. PubMed ID: 23389476
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
[TBL] [Abstract][Full Text] [Related]
10. Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass.
Menasché P; Peynet J; Haeffner-Cavaillon N; Carreno MP; de Chaumaray T; Dillisse V; Faris B; Piwnica A; Bloch G; Tedgui A
Circulation; 1995 Nov; 92(9 Suppl):II334-40. PubMed ID: 7586434
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid reduction of bronchial epithelial inflammation during cardiopulmonary bypass.
Hill GE; Snider S; Galbraith TA; Forst S; Robbins RA
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1791-5. PubMed ID: 8520738
[TBL] [Abstract][Full Text] [Related]
12. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass.
TAMAYO E; ALVAREZ FJ; ALONSO O; BUSTAMANTE R; CASTRODEZA J; SORIA S; LAJO C
J Cardiovasc Surg (Torino); 2009 Oct; 50(5):687-94. PubMed ID: 19741581
[TBL] [Abstract][Full Text] [Related]
13. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass.
Tárnok A; Hambsch J; Emmrich F; Sack U; van Son J; Bellinghausen W; Borte M; Schneider P
Pediatr Cardiol; 1999; 20(2):113-25. PubMed ID: 9986887
[TBL] [Abstract][Full Text] [Related]
14. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10.
Giomarelli P; Scolletta S; Borrelli E; Biagioli B
Ann Thorac Surg; 2003 Jul; 76(1):117-23. PubMed ID: 12842524
[TBL] [Abstract][Full Text] [Related]
15. Humoral immune response during coronary artery bypass grafting: A comparison of limited approach, "off-pump" technique, and conventional cardiopulmonary bypass.
Diegeler A; Doll N; Rauch T; Haberer D; Walther T; Falk V; Gummert J; Autschbach R; Mohr FW
Circulation; 2000 Nov; 102(19 Suppl 3):III95-100. PubMed ID: 11082370
[TBL] [Abstract][Full Text] [Related]
16. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
[TBL] [Abstract][Full Text] [Related]
17. The influence of selective pulmonary perfusion on the inflammatory response and clinical outcome of patients with chronic obstructive pulmonary disease undergoing cardiopulmonary bypass.
Kiessling AH; Guo FW; Gökdemir Y; Thudt M; Reyher C; Scherer M; Beiras-Fernandez A; Moritz A
Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):732-9. PubMed ID: 24632426
[TBL] [Abstract][Full Text] [Related]
18. Capillary leak syndrome after cardiopulmonary bypass in elective, uncomplicated coronary artery bypass grafting operations: does it exist?
Tassani P; Schad H; Winkler C; Bernhard A; Ettner U; Braun SL; Eising GP; Kochs E; Lange R; Richter JA
J Thorac Cardiovasc Surg; 2002 Apr; 123(4):735-41. PubMed ID: 11986602
[TBL] [Abstract][Full Text] [Related]
19. Systemic leukocyte filtration during cardiopulmonary bypass.
Fabbri A; Manfredi J; Piccin C; Soffiati G; Carta MR; Gasparotto E; Nardon G
Perfusion; 2001 Mar; 16 Suppl():11-8. PubMed ID: 11334202
[TBL] [Abstract][Full Text] [Related]
20. Effect of hemoadsorption during cardiopulmonary bypass surgery - a blinded, randomized, controlled pilot study using a novel adsorbent.
Bernardi MH; Rinoesl H; Dragosits K; Ristl R; Hoffelner F; Opfermann P; Lamm C; Preißing F; Wiedemann D; Hiesmayr MJ; Spittler A
Crit Care; 2016 Apr; 20():96. PubMed ID: 27059056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
